Contact
searchSearch
HMP Global
Clinical Videos

BASILICA With Adjunctive Coronary Protection Enabling Valve-in-Valve Transcatheter Aortic Valve Implantation

Konstantinos Stathogiannis, MD, FACC
Michael Chrissoheris, MD
Kyriakos Katsianos, MD
Vivi Grammata, MD
Alexis Dimas, MD
Konstantinos Spargias, MD
12/29/2025

Video 1. Bioprosthetic valve leaflet laceration.

Video 2. Implantation of a 20-mm balloon-expandable SAPIEN 3 Ultra RESILIA (Edwards Lifesciences).

© 2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates. 
 


Related Content

Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a...
01/27/2026
Cath Lab Digest
Original Contribution
Survival With Aortic Valve Replacement in Asymptomatic Individuals With Severe Aortic Stenosis and a Left Ventricular Ejection Fraction of 50% to 54%
01/15/2026
Muhammad Etiwy, MD; Adam N. Berman, MD, MPH; Michael H. Picard, MD; Chiara Fraccaro, MD, PhD; Nicole Karam, MD, PhD; Meagan M. Wasfy, MD, MPH; Yunong Zhao, MS; Magdi Zordok, MD; John Hsu, MD, MBA, MSCE; Jason H. Wasfy, MD, MPhil
The authors compared the outcomes of asymptomatic individuals with severe high gradient aortic stenosis and a left ventricular ejection fraction of 50% to 54% who received aortic valve replacement (AVR) with those who did not receive AVR.
The authors compared the outcomes of asymptomatic individuals with severe high gradient aortic stenosis and a left ventricular ejection fraction of 50% to 54% who received aortic valve replacement (AVR) with those who did not receive AVR.
The authors compared the...
01/15/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of Facilitated Transfemoral Versus Alternative Access for Transcatheter Aortic Valve Replacement in Patients With Peripheral Arterial Disease
01/08/2026
Ahmad Mustafa, MD; Denny Wang, BS ; Cole Dutton, BS; Arber Kodra, MD; Muhammad Abubakar Shakir, MD; Ythan Goldberg, MD; Mei Chau, MD; Shankar Thampi, MD; Priti Mehla, MD; Chapman Wei, MD; Shangyi Liu, MS; Michael Cinelli, MD; Bruce Rutkin, MD; Elana Koss, MD; Gregory Maniatis, MD; Alexander Iribarne, MD; Apurva Patel, MD; Sean Wilson, MD; Wally Omar, MD; Robert Kalimi, MD; Alan Hartman, MD; Jacob Scheinerman, MD; Chad Kliger, MD, MS
The authors evaluates early outcomes of facilitated transfemoral access compared to alternative access in patients with severe peripheral arterial disease.
The authors evaluates early outcomes of facilitated transfemoral access compared to alternative access in patients with severe peripheral arterial disease.
The authors evaluates early...
01/08/2026
Journal of Invasive Cardiology

News

thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

Bangalore top 10
Author Interview
Editor’s 2025 Top 10: Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease
02/02/2026
Sripal Bangalore, MD, MHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Editor's 2025 Top 10
Editor's Message
Editor’s 2025 Top 10
02/02/2026
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
Sovari Figure 1
Clinical Videos
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a...
01/28/2026
Journal of Invasive Cardiology
Bradt Figure
Clinical Videos
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal...
01/28/2026
Journal of Invasive Cardiology
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Heart Failure Devices
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
01/27/2026
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected...
01/27/2026
Cath Lab Digest
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a...
01/27/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use